Trial
NCT01997255
Adjunctive Everolimus (RAD 001) Therapy for Epilepsy in Children With Sturge-Weber Syndrome (SWS)
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Baylor College of Medicine
Collaborators
Novartis Pharmaceuticals
Condition
Sturge Weber Syndrome
Intervention
Everolimus
Why stopped
Site did not want to pursue study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-05-05